- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02281877
Alterations in Muscle After Total Knee Arthroplasty
7. juni 2021 opdateret af: University of Colorado, Denver
Alterations in Skeletal Muscle Gene Expression Following Total Knee Arthroplasty
The overall goals of this work are: 1) to elucidate alterations in gene expression and downstream protein synthesis 2 weeks after Total Knee Arthroplasty (TKA) to better explain quadriceps muscle atrophy after TKA and 2) understand the mechanisms responsible for improved maintenance of muscle strength with Neuromuscular Electrical Stimulation (NMES) utilization.
Furthermore, this investigation seeks to expand previous findings regarding attenuation of strength and functional performance deficits with NMES application to better understand how altered gene expression influences muscle function.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
20
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- University of Colorado School of Medicine
-
Aurora, Colorado, Forenede Stater, 80045
- Univeristy of Colorado Anschutz Medical Campus
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
50 år til 75 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- 50 to 75 years of age
- Scheduled for unilateral TKA at University of Colorado Hospital
- Diagnosed with osteoarthritis
- Cognitive status that allows patients to consistently comprehend and repeat back directions regarding the details of the study
Exclusion Criteria:
- Neurological, vascular or cardiac problems that significantly limit function
- BMI > 35
- Testosterone supplementation
- Pregnancy
- Anticoagulant therapy
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Neuromuscular Electrical Stimulation
Neuromuscular Electrical Stimulation (NMES) 48 hours after TKA, 5x/week, 2x/day, for 45 minutes/session. Standard Rehabilitation Protocol |
5x/week, 2x/day, for 45 minutes/session
Standard physical therapy after TKA
|
Aktiv komparator: Control
Standard Rehabilitation Protocol
|
Standard physical therapy after TKA
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Catabolic gene expression
Tidsramme: Change in gene expression from immediately pre surgery to 2 weeks after surgery
|
Standard procedures including total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image acquisition will be performed.
Protein content (translation of MAFbx, MuRF1, myostatin) will be analyzed.
Total RNA (500 ng) will be reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA), and quantitative PCR will be performed using primer sets for genes of interest, reference genes and iQ SYBR Supermix (Bio-Rad) following manufacturer's protocols.
|
Change in gene expression from immediately pre surgery to 2 weeks after surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Changes in quadriceps strength
Tidsramme: 3 days Pre operative and 2 weeks post operative
|
Isometric quadriceps strength will be using a doublet interpolation test performed by research assistants blinded to participants' treatment randomization.
Briefly, patients will be seated and stabilized in a HUMAC NORM (Computer Sports Medicine Incorporated, Stoughton, MA) dynamometer with their knee flexed to 60 degrees.
After proper warm up, patients will be asked to perform a maximum voluntary isometric contraction of their quadriceps while receiving verbal reinforcement.
|
3 days Pre operative and 2 weeks post operative
|
Changes in quadriceps size
Tidsramme: 3 days Pre operative and 2 weeks post operative
|
Peripheral Quantitative Computed Tomography scans of the distal femur will be used to assess the changes in quadriceps muscle morphology quantitatively.
The maximal cross-sectional area of the quadriceps will be determined prior to TKA and ~14 days after TKA by manually placing the scanner at a line marked on the vastus lateralis one third of the distance between the greater trochanter and the lateral epicondyle of the femur.
The pQCT software will analyze the image and calculate muscle cross-sectional area.
A previous investigation by Cramer, et al. validated the pQCT to measurement of muscle cross-sectional area by comparison to MRI and (R2 values of 0.979 and 0.983).
In addition, the use of the pQCT to measure muscle cross sectional area had high test-retest reliability, with ICC values of 0.996 and 0.998.
|
3 days Pre operative and 2 weeks post operative
|
Changes in quadriceps activation
Tidsramme: 3 days Pre operative and 2 weeks post operative
|
Isometric quadriceps activation testing will be using a doublet interpolation test performed by research assistants blinded to participants' treatment randomization.
Briefly, patients will be seated and stabilized in a HUMAC NORM (Computer Sports Medicine Incorporated, Stoughton, MA) dynamometer with their knee flexed to 60 degrees.
After proper warm up, patients will be asked to perform a maximum voluntary isometric contraction of their quadriceps while receiving verbal reinforcement.
During the contraction, a 2 pulse, 600 µs duration/pulse, supramaximal 100Hz stimulus will be delivered to the muscle to assess whether the subject is indeed maximally contracting the quadriceps muscle and again at rest.
|
3 days Pre operative and 2 weeks post operative
|
Functional Performance Measures (4 meter walk test, timed up and go, stair climbing test)
Tidsramme: 3 days Pre operative and 2 weeks post operative
|
The timed Stair Climbing Test (SCT) places a high demand on the quadriceps and therefore measures a higher level of function and, therefore, minimizes the possibility of a ceiling effect.
The SCT has been shown to significantly correlate to the Timed Up and Go (TUG).
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.25
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).25
The 4 meter Walk Test (4mWT) will be assessed at the fastest safe speed for each participant.
|
3 days Pre operative and 2 weeks post operative
|
Anabolic Gene Expression
Tidsramme: Immediately pre surgery to 2 weeks after surgery
|
Standard procedures including total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image acquisition will be performed.
Protein content (translation of mTOR, myogenin, and MyoD) will be analyzed.
Total RNA (500 ng) will be reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA), and quantitative PCR will be performed using primer sets for genes of interest, reference genes and iQ SYBR Supermix (Bio-Rad) following manufacturer's protocols.
|
Immediately pre surgery to 2 weeks after surgery
|
Muscle Fiber Cross-Sectional Area
Tidsramme: Immediately pre surgery to 2 weeks after surgery
|
Cross sectional area of individual myofibrils taken from the vastus lateralis muscle using immunohistochemical staining and microscopy to determine change in cross sectional area comparing one hour before surgery to two weeks after surgery
|
Immediately pre surgery to 2 weeks after surgery
|
Changes in neural cell adhesion molecule (NCAM) concentration
Tidsramme: Preop and 2 weeks postop
|
NCAM will be assessed by immunohistochemistry with anti-CD56/NCAM antibody (555514; BD Biosciences, San Jose, CA), followed by goat anti-mouse AF555 (A-21127, ThermoFisher).
NCAM is a multifunctional cell-surface protein that has been shown to be associated with muscle regeneration, through its roles in neurite outgrowth and synaptic plasticity.
NCAM immunohistochemistry will be able to assess 1) denervation status, 2) skeletal muscle response to an intervention, and 3) the capacity for skeletal muscle to improve.
|
Preop and 2 weeks postop
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Victor Cheuy, PhD, University of Colorado, Denver
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. oktober 2014
Primær færdiggørelse (Faktiske)
9. marts 2020
Studieafslutning (Faktiske)
9. marts 2020
Datoer for studieregistrering
Først indsendt
7. oktober 2014
Først indsendt, der opfyldte QC-kriterier
30. oktober 2014
Først opslået (Skøn)
4. november 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
9. juni 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
7. juni 2021
Sidst verificeret
1. juni 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 14-0905
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Knæ slidgigt
-
Smith & Nephew, Inc.Nor Consult, LLCAfsluttetJourney II XR Total Knee SystemForenede Stater
-
Smith & Nephew, Inc.AfsluttetSikkerhed og ydeevne af Journey II BCS Total Knee System Patient rapporterede resultatmål (JIIPROMS)Journey II BCS Total Knee SystemForenede Stater, Belgien, New Zealand
-
Smith & Nephew, Inc.Nor ConsultAfsluttetJourney II CR Total Knee SystemForenede Stater
-
Maxx Orthopedics IncRekrutteringKnogletab | Periprotetiske frakturer | Infektion | Aseptisk Løsning | MCL - Medial Collateral Ligament Rupture of the KneeForenede Stater
Kliniske forsøg med Neuromuscular electrical stimulation (NMES)
-
Oregon Health and Science UniversityAfsluttet
-
University of Maryland, BaltimoreIkke rekrutterer endnuKritisk sygdom | Sarkopeni | ICU erhvervet svaghedForenede Stater
-
Wolfgang Fitz, M.D.CyMedica Orthopedics, IncAfsluttetTotal knæarthroplastikForenede Stater
-
University Hospital MuensterUkendtSlag | Dysfagi | EkstubationsfejlTyskland
-
University of Maryland, BaltimoreAktiv, ikke rekrutterendeKritisk sygdom | Muskelsvaghed | SarkopeniForenede Stater
-
Phagenesis Ltd.NAMSA; Cytel Inc.RekrutteringDysfagiFinland, Schweiz, Østrig, Tyskland
-
The Hong Kong Polytechnic UniversityUkendt
-
University of MichiganSpring Arbor UniversityAfsluttet
-
Federal University of Health Science of Porto AlegreIkke rekrutterer endnuRekonstruktion af forreste korsbånd | Rehabilitering af forreste korsbåndBrasilien
-
Research Institute for Complex Problems of Cardiovascular...UkendtHjertefejl | Sarkopeni | Perifer arteriesygdom | Træn intoleranceDen Russiske Føderation